Skip to contentT
Thermo Fisher Scientific Inc.
T
TMOThermo Fisher Scientific Inc. Q1 2021 · 10-Q
Revenue$9.91B$9.91B+59.0% vs Q1 2020 Net Income$2.34B$2.34Bno prior Q1 2020 on file EPS Diluted$5.88$5.88+198.5% vs Q1 2020 Operating Income$3,049,000,000+236.5% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
Free Cash Flowderived$1,350,000,000+1,210.7% Margins · derivedOperating margin30.8%+16.2 pt vs Q1 2020
Net margin23.6%
ended Apr 3, 2021 · filed May 7, 2021 · 34 d after period end